Caixin Deep Dive: Chinese Drugmakers Navigate Opportunities and Challenges in Indonesia

Companies have to contend with local protectionism, cultural differences and an underdeveloped health care sector while exploring growth potential in Southeast Asia’s largest economy Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: In Depth: Chinese Drugmakers Find Fertile, but Challenging Market in Indonesia Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a 66% discount. Group discounts are available — contact us for a customized plan.